ÂÜÀòÂÒÂ×

Mike Eldon is a Partner and Expert Consultant in Clinical Pharmacology, Pharmacokinetics, and Pharmacometrics at NDA Partners, providing consulting services since June 2017 to pharmaceutical companies in areas such as PK, PKPD, Translational Sciences, and Clinical Study Design. With prior experience as Vice President of Clinical Pharmacology at Nektar Therapeutics from November 1997 to June 2017, Mike specialized in the design and development of drug products using PEGylation and inhalation technologies. Earlier, as a Research Fellow at Parke-Davis Pharmaceutical Research from October 1982 to November 1997, Mike contributed to the development and registration of numerous drug products across various therapeutic areas, including well-known medications such as Lipitor and Neurontin. Education includes a BSPharm and PhD in Pharmacy, Biopharmaceutics, and Pharmacokinetics from the University of Cincinnati.